0001567619-23-004537.txt : 20230306
0001567619-23-004537.hdr.sgml : 20230306
20230306184639
ACCESSION NUMBER: 0001567619-23-004537
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230302
FILED AS OF DATE: 20230306
DATE AS OF CHANGE: 20230306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dupont Jakob
CENTRAL INDEX KEY: 0001553335
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36548
FILM NUMBER: 23710459
MAIL ADDRESS:
STREET 1: C/O ONCOMED PHARMACEUTICALS, INC.
STREET 2: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Atara Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001604464
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 460920988
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2380 CONEJO SPECTRUM ST
STREET 2: SUITE 200
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
BUSINESS PHONE: 805-623-4244
MAIL ADDRESS:
STREET 1: 2380 CONEJO SPECTRUM ST
STREET 2: SUITE 200
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
4
1
doc1.xml
FORM 4
X0306
4
2023-03-02
0
0001604464
Atara Biotherapeutics, Inc.
ATRA
0001553335
Dupont Jakob
C/O ATARA BIOTHERAPEUTICS, INC.
2380 CONEJO SPECTRUM ST, SUITE 200
THOUSAND OAKS
CA
91320
0
1
0
0
EVP, Head of R&D
Common Stock
2023-03-02
4
S
0
5074
3.627
D
290794
D
Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations in connection with the vesting of previously granted restricted stock units.
The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on March 2, 2023 and March 3, 2023 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee.
/s/ Jeff Kiekhofer, Attorney-in-Fact for Jakob Dupont
2023-03-06